【皮肤病生物制药公司】Biofrontera Inc.（BFRI）美股招股说明书 S-1（2025-07-16首版）（英文版）（53页）.pdf

1、S-1 1 forms-1.htm S-1 As filed with the Securities and Exchange Commission on July 16,2025.Registration No.333-UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWashington,D.C.20549 FORM S-1REGISTRATION STATEMENTUNDERTHE SECURITIES ACT OF 1933 BIOFRONTERA INC.(Exact name of registrant as specified in i

2、ts charter)Delaware 2834 47-3765675(State or other jurisdiction ofincorporation or organization)(Primary Standard IndustrialClassification Code Number)(I.R.S.EmployerIdentification No.)120 Presidential Way,Suite 330Woburn,MA 01801Telephone:781-245-1325(Address,including zip code,and telephone number

3、,including area code,of registrants principal executive offices)Prof.Hermann LuebbertChairman and Chief Executive OfficerBiofrontera Inc.120 Presidential Way,Suite 330Woburn,MA 01801Telephone:781-245-1325(Name,address,including zip code,and telephone number,including area code,of agent for service)C

4、opies to:Stephen E.Older,Esq.Andrew J.Terjesen,Esq.McGuireWoods LLP1251 Avenue of the Americas20th FloorNew York,NY 10020Telephone:212-548-2100 Daniel HakanssonCorporate CounselBiofrontera Inc.120 Presidential Way,Suite 330Woburn,MA 01801Telephone:781-486-1510 APPROXIMATE DATE OF COMMENCEMENT OF PRO

5、POSED SALE TO THE PUBLIC:FROM TIME TO TIMEAFTER THIS REGISTRATION STATEMENT IS DECLARED EFFECTIVE.If any of the securities being registered on this form are to be offered on a delayed or continuous basis pursuant to Rule 415 underthe Securities Act of 1933,check the following box.If this form is fil

6、ed to register additional securities for an offering pursuant to Rule 462(b)under the Securities Act,check thefollowing box and list the Securities Act registration statement number of the earlier effective registration statement for the sameoffering.If this form is a post-effective amendment filed